Zomibet 2 Dry Vial Of 1 Powder For Injection
1 Powder For Injection(s) in Dry VialMRP ₹12200.00
₹10580.00
13% OFF
Made by
SUN PHARMA
Dosage
POWDER FOR INJECTION
Expiry
Product Summary
| Uses | Multiple myeloma: This condition affects plasma cells in the bone marrow; bortezomib helps control abnormal cell growth and may slow disease progression., Mantle cell lymphoma: This blood cancer affects abnormal lymphocytes; bortezomib helps destroy these cells and may slow progression. |
| Therapy | Anti-neoplastic |
| Side effects | Numbness or tingling: Bortezomib can affect nerves, causing pins and needles, burning or reduced feeling in the hands or feet. Report worsening symptoms promptly., Fever: Treatment can reduce infection-fighting blood cells, so fever or chills may signal infection. Contact the treatment team urgently., Nausea: Bortezomib treatment can upset the stomach and reduce appetite. Tell the treatment team if nausea stops you drinking fluids., Vomiting: Treatment may trigger vomiting and dehydration. Seek prompt medical help if you cannot keep fluids down or feel faint., Tiredness: Treatment can cause marked fatigue or weakness that limits daily activity. Report sudden worsening, fainting or breathlessness to the oncology team. |
| Salt Content | Bortezomib(2.0 Mg) |
Assurance
available
Regulated
Medical Description
Zomibet Dry powder for injection is a specialist medicine used to treat multiple myeloma and mantle cell lymphoma, serious conditions affecting abnormal blood cells. It contains bortezomib, which blocks proteasomes, cell structures that break down unwanted proteins. This buildup disrupts abnormal cells and can slow their growth or cause them to die. Zomibet Dry powder for injection is prepared and given by a doctor or nurse in a hospital or clinic, with monitoring during treatment.
Uses
- Multiple myeloma: This condition affects plasma cells in the bone marrow; bortezomib helps control abnormal cell growth and may slow disease progression.
- Mantle cell lymphoma: This blood cancer affects abnormal lymphocytes; bortezomib helps destroy these cells and may slow progression.
Contraindications
Side effects
- Numbness or tingling: Bortezomib can affect nerves, causing pins and needles, burning or reduced feeling in the hands or feet. Report worsening symptoms promptly.
- Fever: Treatment can reduce infection-fighting blood cells, so fever or chills may signal infection. Contact the treatment team urgently.
- Nausea: Bortezomib treatment can upset the stomach and reduce appetite. Tell the treatment team if nausea stops you drinking fluids.
- Vomiting: Treatment may trigger vomiting and dehydration. Seek prompt medical help if you cannot keep fluids down or feel faint.
- Tiredness: Treatment can cause marked fatigue or weakness that limits daily activity. Report sudden worsening, fainting or breathlessness to the oncology team.
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You notice new or worsening numbness, tingling, or pain in your hands and feet (signs of peripheral neuropathy).
- You experience sudden shortness of breath, cough, or breathing difficulties, which require urgent evaluation for lung inflammation.
- You develop signs of infection, fever, or unusual bruising and bleeding.
- You experience symptoms of heart problems, such as leg swelling or irregular heartbeats.
- You have significant dizziness or fainting.
Directions for Use
Storage and disposal
Quick Tips
- Attend every scheduled appointment and blood test.
- Report numbness, tingling, burning pain or weakness early.
- Contact your treatment team urgently for fever, chills or signs of infection.
- Drink fluids as advised, especially if vomiting or diarrhoea occurs.
- Use reliable contraception as advised by your oncology team.
Dosage
Overdose
Missed a Dose
How does this medicine work?
Interactions
Interactions with other medicines
Interactions with food items
- Zomibet powder for injection is administered by injection, so food does not affect its absorption.
- There is no need for a specific food restriction unless advised by your doctor.
Frequently Asked Questions (FAQs)
References:
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Aug 24].
- electronic medicines compendium (emc). Bortezomib 1 mg powder for solution for injection - Summary of Product Characteristics (SmPC) [Internet]. Sandwich: Accord-UK Ltd; 2023 [cited 2026 Aug 24].
- electronic medicines compendium (emc). Bortezomib 3.5 mg powder for solution for injection - Summary of Product Characteristics (SmPC) [Internet]. Sandwich: Dr. Reddy's Laboratories (UK) Ltd; 2023 [cited 2026 Aug 24].
- Pfizer Inc. Velcade (bortezomib) powder for solution for injection prescribing information [Internet]. New York: Pfizer Inc; 2022 [cited 2026 Aug 24].
- Ever Pharma New Zealand Ltd. Bortezomib Ever Pharma data sheet [Internet]. Wellington: Medsafe New Zealand; 2021 [cited 2026 Aug 24].
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:ZOMIBET
Country of Origin:India
Vendor Details
Fulfillment Information: Zomibet 2 MG Powder For Injection (1) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.



















